WASHINGTON – A newly released intelligence report identifies fentanyl as a top threat to the United States and, for the first time, places India alongside China as a primary source of illicit fentanyl precursor chemicals.
While the report states that China remains the leading supplier of these chemicals and pill-pressing equipment, it names India as the second-largest source. This marks a significant shift from last year’s assessment, which only mentioned India as one of several countries supplying Mexican cartels to a “lesser extent.” China, at the time, was still recognized as the dominant supplier.
In response to China’s role in fentanyl trafficking, President Donald Trump imposed an additional 10% tariff on Chinese goods on Feb. 1. The White House also levied 25% tariffs on Canada and Mexico, citing inadequate border enforcement. Trump has further threatened reciprocal taxes on multiple nations. However, India is in negotiations with the U.S. to fast-track a free trade agreement, which could potentially shield it from some of these economic penalties.
Notably, Canada was absent from the intelligence report’s threat assessment—despite the Trump administration’s repeated claims that drug trafficking across the northern border poses a major risk to Americans. This omission stands in contrast to Trump’s justification for imposing 25% tariffs on Canadian exports.
